Are the causes of hormone therapy failure due to mutations in the tumor dna or bypass mechanisms? Like if you’ve been on some therapy for a while but then develop a new primary, how is this possible when those receptors are suppressed (assuming the patient is compliant with dosing).
Also, has anyone had the Breast Cancer Index in addition to the oncotype or mamaprint tests? Did it alter treatment decisions? I don’t really understand what it tests but it doesn’t seem as specific as oncotype or mamaprint.
Lastly, has anyone’s oncologist offered or suggested testing to see if you have a difference in the way you metabolize these drugs, or checked to make sure you have therapeutic levels?